Glutalor Medical to Exhibit Its CGM Product at ADA in June, 2016

Published by Admin D on

Glutalor Medical to exhibit its iWel Continuous Glucose Monitoring (CGM) product at the annual American Diabetes Association meeting to be held at New Orleans, Louisiana in June 2016.  Its iWel CG2 CGM device, an improved CGM product, is under filing for European approval.

Categories: News

0 Comments

Leave a Reply

Avatar placeholder

Related Posts

News

IWel Health Announces Addition of Former FDA Deputy Commissioner Dr. Michael A Friedman to Its Scientific Board

IWel Health announces addition of Michael A Friedman, MD, to its Scientific Board. Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.  He served Read more…

News

Glutalor Exhibits its iWel Mobile Glucose CGM Technology at Virtual ADA (American Diabetes Association) 2020 Conference

News

Glutalor Medical Announces Grant of US Patent on its Glucose CGM Technology

Glutalor Medical announces one of its US patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” Dynamic Blood Glucose Data Acquiring Device and Host” was granted Read more…